|
|
Odyssey™ Backbone
Odyssey is an Information Backbone to Manage, Control, Record and Share Your Labs
Odyssey™ Workstation
The Odyssey Workstation is a groundbreaking product which gathers lab data into an information backbone with a single display and control as though you are operating one system
Odyssey™ Cinema
Odyssey Cinema is an unparalleled solution delivering real-time, remote views of live and archived case information anywhere you can access your hospital network.
Odyssey™ Connect
Odyssey Connect is an unprecedented solution linking your hospital to the world with independent sharing of labs for collaboration and on demand support.
|
|
Stereotaxis Reports 16% Revenue Increase in the Fourth Quarter 2009
Thursday, February 25, 2010
--New Orders Up 22% Sequentially; Second Consecutive Quarterly Increase --Recurring Revenue Reaches Record $5.1 Million --Cash Burn Declines to $2.9 Million --Full Year 2009 Revenue Up 27%; Gross Margin Percentage of 67%; Operating Expenses Decrease 14%ST. LOUIS, Feb 25, 2010 /PRNewswire via COMTEX/ -- Stereotaxis, Inc. (Nasdaq: STXS) today reported its financial results for the quarter and the year ended December 31, 2009. Revenue for the recent fourth quarter grew 16% to $14.1 million compared with $12.1 million in the same quarter a year ago. The Company recognized revenue on six Niobe(R) Magnetic Navigation Systems, nine Odyssey(TM) systems and four Odyssey Cinema(TM) systems, totaling $9.0 million. Disposables, services and accessories revenue set another record at $5.1 million, a 51% increase from the fourth quarter of 2008, attributable to favorable pricing and procedure growth. The 2009 fourth quarter operating loss decreased 9% to $5.8 million from $6.4 million in 2008.
For the full year 2009, revenue grew 27% to $51.1 million compared with $40.4 million in 2008. Recurring revenue increased 54% to $18.5 million from $12.0 million in 2008. Gross margin for the year was up 30% to $34.1 million, or 66.7% of sales, compared with 64.9% of sales in 2008. Operating expenses decreased 14%, resulting in a 42% reduction in the operating loss to $23.8 million in 2009 compared with the $41.0 million operating loss in 2008.
Read More... "Stereotaxis Reports 16% Revenue Increase in the Fourth Quarter 2009"
Stereotaxis Procedure Prominently Featured on BBC Documentary From the Heart
Thursday, February 18, 2010
ST. LOUIS, Feb 17, 2010 /PRNewswire via COMTEX/ -- Stereotaxis (Nasdaq: STXS) announced that the recent BBC documentary "From the Heart" included a cardiac ablation procedure performed with the Stereotaxis System by Dr. Muchtiar Khan of OLVG Hospital in Amsterdam. The program's second half, beginning at 10:30 of the 25-minute run time, features extensive scenes from the Stereotaxis procedure. The documentary highlights how treatment of complex left atrial arrhythmias can reduce the growing prevalence of stroke. The documentary portrays Stereotaxis as an effective alternative to anti-arrhythmic drugs, and includes a visually compelling demonstration of the system's precise control of a magnetic catheter. The documentary is available at http://bit.ly/9e3C5P
Read More... "Stereotaxis Procedure Prominently Featured on BBC Documentary From the Heart"
Stereotaxis Announces Fourth Quarter 2009 Earnings Release Date and Conference Call
Tuesday, February 9, 2010
Stereotaxis Installs First System in Taiwan
Monday, February 8, 2010
Stereotaxis System Procedure Featured on NBC's The TODAY Show
Monday, February 1, 2010
Stereotaxis Reports 26% Third Quarter 2009 Revenue Growth
Thursday, November 5, 2009
Stereotaxis Receives Notice of European Approval of an Additional Magnetic Irrigated Catheter
Friday, October 30, 2009
Stereotaxis Announces Third Quarter 2009 Earnings Release Date and Conference Call
Thursday, October 22, 2009
Stereotaxis Announces Underwriters' Exercise of Over-Allotment Option
Monday, October 12, 2009
Stereotaxis Announces Pricing of $26 Million Common Stock Offering
Friday, October 9, 2009
Stereotaxis Announces Public Offering of Common Stock
Thursday, October 8, 2009
Stereotaxis Receives Commitment to Increase and Extend Its Credit Facility With Silicon Valley Bank
Wednesday, October 7, 2009
Stereotaxis Showcases Interventional Value of Magnetic Navigation at TCT 2009
Thursday, September 24, 2009
Texas Cardiac Arrhythmia Institute at St. David's Medical Center Orders 4 Odyssey Systems
Tuesday, September 15, 2009
Stereotaxis Awarded Exclusive Contract by Novation for Robotic Interventional Technology
Thursday, September 10, 2009
Magnet-guided flexible catheter at Spectrum Health's Heart Center cures teen's rapid heartbeat
Thursday, August 6, 2009
Spotlight Interview: The University of Kansas Hospital
Saturday, August 1, 2009
Arrhythmia Center of Stockholm consider Stereotaxis key addition to their complex ablation programs
Saturday, August 1, 2009
2,500 Cases Completed With the Magnetic Irrigated Catheter
Wednesday, August 5, 2009
High-tech 'heart burn' helps cardiac patients
Sunday, July 5, 2009
Stereotaxis' Market Leadership Highlighted at Heart Rhythm 2009
Monday, May 11, 2009
Stereotaxis Extends Its Credit Facility With Silicon Valley Bank
Monday, March 16, 2009
Stereotaxis Signs Agreement With Leading Leasing Specialist to Offer Alternative Financing to Hospital Customers
Thursday, March 12, 2009
Stereotaxis Announces First Uses of the NAVISTAR(R) RMT THERMOCOOL(R) Catheter
Friday, March 6, 2009
Stereotaxis Announces FDA Approval of the NAVISTAR(R) RMT THERMOCOOL(R) Catheter
Friday, February 27, 2009
|
